Related Experiment Video
Updated: Jul 14, 2026

Determination of Biofilm Initiation on Virus-infected Cells by Bacteria and Fungi
Published on: July 6, 2016
Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma
1Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Abstract:
Attenuated, replication-competent, oncolytic herpes simplex virus type 1 (HSV-1) are effective at infecting and lysing many human malignancies in preclinical studies. Nectin-1 is a cell-surface receptor for HSV-1 envelope glycoprotein D (gD) that also forms a component of intercellular adherens junctions (AJs). We sought to determine if the disruption of AJs in squamous cell carcinoma (SCC) through calcium depletion could be utilized to increase nectin-1 exposure and enhance HSV therapy. NV1023 is a single copy gamma(1)34.5-deleted, lacZ-expressing, oncolytic HSV-1. Calcium depletion caused cell separation and increased nectin-1 expression for three SCC cell lines growing at confluence. NV1023 viral entry, soluble gD protein binding and NV1023 cytotoxicity were all significantly enhanced for these cell lines at low calcium conditions. The increase in NV1023 entry at low calcium conditions was abrogated by nectin-1 antibody blockade. Murine SCC flank tumors treated with ethylenediaminetetraacetic acid (EDTA) showed increased nectin-1 expression and increased susceptibility to NV1023 infection. Combined NV1023 and EDTA intratumoral injections demonstrated significantly enhanced tumor regression as compared to NV1023 alone. These findings establish, as proof-of-principle, that herpes viral receptor expression may be modulated on cancer cells to enhance oncolytic therapy. This strategy might have future application toward improving therapy with a variety of herpes vectors.
Insights
Calcium depletion enhances oncolytic herpes simplex virus type 1 (HSV-1) therapy for squamous cell carcinoma (SCC) by increasing nectin-1 receptor expression. This strategy improves viral entry and tumor regression, offering a novel approach to cancer treatment.
Area of Science:
- Oncology
- Virology
- Biotechnology
Background:
- Attenuated, oncolytic herpes simplex virus type 1 (HSV-1) show promise in preclinical cancer models.
- Nectin-1, a receptor for HSV-1 glycoprotein D, is also part of intercellular adherens junctions (AJs).
Purpose of the Study:
- To investigate if disrupting AJs via calcium depletion can increase nectin-1 exposure and enhance HSV-1 oncolytic therapy in squamous cell carcinoma (SCC).
Main Methods:
- Utilized calcium depletion in SCC cell lines and murine SCC flank tumors.
- Administered NV1023, an oncolytic HSV-1, with and without ethylenediaminetetraacetic acid (EDTA).
- Assessed nectin-1 expression, viral entry, binding, cytotoxicity, and tumor regression.
Main Results:
- Calcium depletion increased nectin-1 expression and cell separation in SCC cell lines.
- NV1023 viral entry, soluble gD protein binding, and cytotoxicity were enhanced under low calcium conditions.
- Combined NV1023 and EDTA treatment significantly improved tumor regression in murine SCC models.
Conclusions:
- Disrupting adherens junctions by calcium depletion enhances nectin-1 receptor expression on cancer cells.
- This modulation strategy significantly improves the efficacy of oncolytic HSV-1 therapy.
- This approach holds potential for enhancing therapies using various herpes vectors.
Related Concept Videos
Herpes
Genital Herpes
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Cytotoxic Edema: Pathophysiology
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

